Global Retirement Partners, LLC Mirati Therapeutics, Inc. Transaction History

Global Retirement Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$41.99 - $62.38 $209 - $311	5 Added 25.0%	25 $1,000
Q3 2023 Oct 13, 2023	SELL	$27.8 - $45.35 $528 - $861	-19 Reduced 48.72%	20 $0
Q2 2023 Jul 20, 2023	BUY	$36.13 - $49.49 $289 - $395	8 Added 25.81%	39 $1,000
Q1 2023 May 05, 2023	BUY	$36.54 - $54.26 $950 - $1,410	26 Added 520.0%	31 $1,000
Q4 2022 Feb 13, 2023	SELL	$41.27 - $98.62 $4,415 - $10,552	-107 Reduced 95.54%	5 $0

Q3 2022 Nov 03, 2022	SELL	$59.5 - $86.7 $238 - $346	-4 Reduced 3.45%	112 $8,000
Q2 2022 Jul 15, 2022	BUY	$39.16 - $88.71 $548 - $1,241	14 Added 13.73%	116 $8,000
Q1 2022 Jul 14, 2022	BUY	$75.82 - $150.97 $7,733 - $15,398	102 New	102 $6,000
Q4 2021 Jan 21, 2022	SELL	$132.01 - $190.29 $5,808 - $8,372	-44 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$132.13 - $177.45 $5,813 - $7,807	44 New	44 $8,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Global Retirement Partners, LLC with notifications on news.